Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Fitxers

663298.pdf (614.74 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2016

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/167261

Efficacy and safety of a dietary supplement containing a lipid co-extract from Serenoa repens and Pygeum africanum for the treament of androgenetic alopecia (AGA) in women. Results of a randomized, double-blind, placebo-controlled clinical trial

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.5538/1887-5181.2016.25.5

Resum

Background: Few clinical trials have assessed the usefulness of Serenoa repens and Pygeum africanum for the treatment of androgenetic alopecia (AGA). Purpose: To assess the efficacy of a dietary supplement (RJ-SP4AGA) containing a lipid co-extract from Serenoa repens and Pygeum africanum in post-menopausal women with AGA. Methods: A randomized, double-blind, placebo-controlled clinical trial was performed in post-menopausal women with AGA, who received RJ-SP4AGA capsules or placebo capsules (two capsules/day during 16 weeks). At baseline, after 8 and 16 weeks, a phototrichogram analysis (anagen and telogen hair), a pull test (hair resistance to traction) and tolerability assessments were performed. Results: A total of 40 Caucasian women were included, with a mean age of 58 years. After 16 weeks of treatment with RJ-SP4AGA capsules, anagen hair significantly increased and telogen hair significantly decreased (as mean %), with significant differences in comparison with placebo (p< 0.001). Hair resistance to traction also increased after 8 and 16 weeks in both groups. The RJ-SP4AGA capsules were well tolerated during treatment. Conclusions: The dietary supplement RJ-SP4AGA capsules is useful in reverting the signs of AGA in post-menopausal women.

Matèries

Alopècia, Menopausa

Matèries (anglès)

Baldness, Menopause

Citació

Col·leccions

Articles publicats en revistes (Biologia, Sanitat i Medi Ambient)

Citació

BORRÀS ANDRÉS, Josep Maria, et al. Efficacy and safety of a dietary supplement containing a lipid co-extract from Serenoa repens and Pygeum africanum for the treament of androgenetic alopecia (AGA) in women. Results of a randomized, double-blind, placebo-controlled clinical trial. Más Dermatología: Actualidad y avances . 2016. Vol. 25, num. 5-14. ISSN 2013-7338. [consulted: 21 of August of 2026]. Available at: https://hdl.handle.net/2445/167261

Exportar metadades

JSON - METS

Compartir registre